bitsCrunch’s BCUT token’s community sale concludes in 24 minutes
bitsCrunch’s BCUT token’s community sale concludes in 24 minutes bitsCrunch, a decentralised AI-powered Web3.0 analytics network, has announced that the community sale of BCUT – the native utility and governance token for the bitsCrunch network – sold out in 24 minutes. According to an official release, the community sale raised $3.85 million and added more than 3,300 unique token holders to the bitsCrunch community. With over 38,000 unique registrants and participation from 163 countries, the BCUT community sale reportedly made seven percent of the total supply of 70,000,000 BCUT available at a price of $0.055 per token. Prior to the sale, it’s believed that registrants funded their wallets with $21 million. “As we march towards mainnet launch, I believe this community sale bookends a year of growth for our network in 2023, and we look forward to building on this momentum in 2024,” Vijay Pravin, founder and CEO, bitsCrunch, said. Follow us onTwitter,Facebook,LinkedIn
相关推荐
DIIs reverse trend, infuse over Rs 12k-cr in 2 weeks
Decoding US Apple Watch import ban- Inside the Apple vs Masimo patent war
Enforcement Directorate summons Delhi CM Kejriwal for third time on Jan 3
Designing sustainability-first solutions with Industry 4
BoI offers 7
DGPs conference- Amit Shah stresses on linking databases, adopting AI-driven analytics to tackle security challenges
- 最近发表
- Will Nifty continue the winning streak to scale past 20900- 8 things to know before the share market opens
- Deal closures taking longer due to higher due diligence
- Yatra Online gets Sebi’s nod to float IPO
- End of Santa Rally- Share markets deep in red today; what’s dragging indices, will correction continue-
- Wipro, IndiGo, Reliance, DreamFolks Services, Adani Power, Paras Defence stocks in focus on 7 September 2022
- Boeing addresses mishap concerns- Here’s what the CEO said amid swift criticism
- Will Nifty surpass the resistance at 19414 or fall further in trade- See GIFT Nifty, FII data, F&O ban, crude, more before market opens
- eMudhra shares list at premium on BSE, NSE; stock gains 6% from IPO price on debut day
- Will the Nifty scale past 19,850- Check GIFT Nifty, FII Data, F&O Ban, Crude, and more before market opens
- Dehradun-Ayodhya daily air service to begin soon- Uttarakhand CM Dhami urges Jyotiraditya Scindia to make Pilgrim travel easier
- 随机阅读
- Dalal Street may stay range-bound until US Fed turns dovish; high earnings downgrades on cards
- Buch completes one year, marked by big-bang reforms
- Bitcoin topped $45,000 for first time in nearly two years
- Bosch, Cummins India, Blue Star among 40 NSE stocks to hit 52-week highs; 38 touch 52-week lows
- Blue Jet Healthcare shares set to debut on bourses; GMP looks favourable
- BofA trims year-end Nifty target to 17,500
- Exporters fear business loss from protracted Red Sea crisis
- Billionaire investor Bill Ackman explains why share market is imploding- Investors lose confidence in US Fed
- Dazzling & Astounding! Proposed design of the to-be redeveloped Dakaniya Talav Railway Station in Rajasthan-PHOTOS
- Do you have potassium deficiency- Know all about it’s signs and symptoms
- s, especially those with taste changes or dietary limits, to stick with the treatment. In a nutshell, BDENZA ORAL SOLUTION is a simpler, more patient-friendly way to tackle prostate cancer. It can help improving the patient compliance to a great extent,” Dr. Aravind Badiger Director, Technical Formulation said in a statement.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.
- Evolution of Medical and Engineering education
- Dow, S&P 500 eye higher open as regional banks rise; key inflation data awaited
- Bournvita row- Cadbury reduces added sugar by around 15 percent from its popular health drink after backlash
- Durga Puja 2023- Hema Malini to Rani Mukerji, Bollywood celebs seek blessings at Puja pandal – See pics
- Examining volatility in Adani shares- Sebi
- Equity fundraising to touch $25 billion in 2023- KIB
- Delhivery’s Rs 5,235-cr IPO goes through amid institutional demand
- Departure of grounded Romanian plane with Indian passengers from French airport delayed- Reports
- BSE reassures investors on refunds on StARMF platform
- 搜索
- 友情链接